標(biāo)題: Titlebook: Bloodtransfusion and Problems of Bleeding; C. Th. Smit Sibinga,P. C. Das,J. J. Loghem (Profes Book 1982 Martinus Nijhoff Publishers, The H [打印本頁(yè)] 作者: Gratification 時(shí)間: 2025-3-21 19:42
書(shū)目名稱Bloodtransfusion and Problems of Bleeding影響因子(影響力)
書(shū)目名稱Bloodtransfusion and Problems of Bleeding影響因子(影響力)學(xué)科排名
書(shū)目名稱Bloodtransfusion and Problems of Bleeding網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Bloodtransfusion and Problems of Bleeding網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Bloodtransfusion and Problems of Bleeding被引頻次
書(shū)目名稱Bloodtransfusion and Problems of Bleeding被引頻次學(xué)科排名
書(shū)目名稱Bloodtransfusion and Problems of Bleeding年度引用
書(shū)目名稱Bloodtransfusion and Problems of Bleeding年度引用學(xué)科排名
書(shū)目名稱Bloodtransfusion and Problems of Bleeding讀者反饋
書(shū)目名稱Bloodtransfusion and Problems of Bleeding讀者反饋學(xué)科排名
作者: Expressly 時(shí)間: 2025-3-21 21:15
Studies in Literature and ReligionBeta-thromboglobulin (BTG), since its isolation and characterization in 1975, has stirred much interest because of its intimate association with the platelet release reaction and because of the increasingly recognized role platelets play in various disease states.作者: 迷住 時(shí)間: 2025-3-22 00:49 作者: visceral-fat 時(shí)間: 2025-3-22 05:09
https://doi.org/10.1007/978-3-030-40256-3In many cases, especially those encountered in intensive care units, patients are transfused massively with blood components to compensate the consequences of blood loss (hypoxemia, hemostasis disorders for example).作者: 滋養(yǎng) 時(shí)間: 2025-3-22 12:16 作者: 河潭 時(shí)間: 2025-3-22 13:49
Beta-Thromboglobulin: A Story of Value?Beta-thromboglobulin (BTG), since its isolation and characterization in 1975, has stirred much interest because of its intimate association with the platelet release reaction and because of the increasingly recognized role platelets play in various disease states.作者: amygdala 時(shí)間: 2025-3-22 19:10 作者: crockery 時(shí)間: 2025-3-22 21:30
Transfusional Prevention of the Massive Transfusion SyndromeIn many cases, especially those encountered in intensive care units, patients are transfused massively with blood components to compensate the consequences of blood loss (hypoxemia, hemostasis disorders for example).作者: homeostasis 時(shí)間: 2025-3-23 05:04
https://doi.org/10.1007/978-94-009-7692-4blood; clinical trial; genetics; hemophilia; pathophysiology; physiology; plasma; vaccine; virus作者: CREEK 時(shí)間: 2025-3-23 05:34 作者: Engaged 時(shí)間: 2025-3-23 13:26
Blood Coagulation: Laboratory Practiceemostatic failure, to diagnose, investigate and if necessary treat a patient with bleeding tendency, and finally, to monitor the effects of blood component therapy. The tests used and the interpretations made depend on the clinical context. Therefore each of the three clinical situations will be discussed separately.作者: 影響 時(shí)間: 2025-3-23 14:03
The Magic of Fresh Whole Bloodhole blood into its components became possible. The availability of blood components fostered their utilization and the concept of ‘component therapy’, or transfusion of the specific fraction of the blood which the patient lacks, has become an increasingly important part in today’s practice of blood transfusion.作者: Fermentation 時(shí)間: 2025-3-23 21:08 作者: Influx 時(shí)間: 2025-3-23 22:24
https://doi.org/10.1007/978-3-319-67660-9emostatic failure, to diagnose, investigate and if necessary treat a patient with bleeding tendency, and finally, to monitor the effects of blood component therapy. The tests used and the interpretations made depend on the clinical context. Therefore each of the three clinical situations will be discussed separately.作者: Osteoporosis 時(shí)間: 2025-3-24 03:50 作者: 值得 時(shí)間: 2025-3-24 10:31 作者: 贊成你 時(shí)間: 2025-3-24 12:30 作者: faucet 時(shí)間: 2025-3-24 15:22 作者: LAPSE 時(shí)間: 2025-3-24 22:03 作者: 混合 時(shí)間: 2025-3-25 02:05
SpringerBriefs in Molecular Sciencehole blood into its components became possible. The availability of blood components fostered their utilization and the concept of ‘component therapy’, or transfusion of the specific fraction of the blood which the patient lacks, has become an increasingly important part in today’s practice of blood作者: 祝賀 時(shí)間: 2025-3-25 06:48 作者: Mnemonics 時(shí)間: 2025-3-25 07:45
https://doi.org/10.1007/978-1-349-22466-1therapy has established itself as an integral and vital component in the management of such patients. Dramatic changes in medical practice, and the full-fledged development of medical oncology as a separate discipline, owe much to the expanding blood component technology which has provided them with作者: 對(duì)手 時(shí)間: 2025-3-25 12:04
https://doi.org/10.1007/978-94-6091-591-8t concentrates has increased considerably, especially in leukemia and oncology units. Routinely prepared platelets have 2–3 days shelf life. The preserved platelets from compatible donors for alloimmunized patients or patients before undergoing treatment, or when they are in remission (autologous pl作者: EVADE 時(shí)間: 2025-3-25 18:23 作者: orthodox 時(shí)間: 2025-3-25 20:23
https://doi.org/10.1007/978-94-6091-591-8ions with respect to host defense. Those fixed macrophages that reside in the liver and spleen and comprise the majority of the RES are uniquely located anatomically such that they can monitor the circulation and have been demonstrated to remove a variety of blood-borne toxic and particulate materia作者: cortisol 時(shí)間: 2025-3-26 01:44 作者: jumble 時(shí)間: 2025-3-26 06:26 作者: legislate 時(shí)間: 2025-3-26 08:39
niversity Hospital Groningen under the directorship of Dr. Van Dijk. All these activities show how much a well-organized blood bank can contribute to a national blood transfusion orga- nization.978-94-009-7694-8978-94-009-7692-4作者: 真 時(shí)間: 2025-3-26 15:47
https://doi.org/10.1007/978-3-319-78913-2rculation disturbances in the legs, kidney disease etc. Thrombin generation therefore is a suitable subject of research in a biochemistry department of a medical faculty. On the other hand it shows so many novel features not recognized in enzymology until now, that it cannot fail to interest even th作者: 脆弱帶來(lái) 時(shí)間: 2025-3-26 19:13 作者: falsehood 時(shí)間: 2025-3-27 00:57 作者: 小臼 時(shí)間: 2025-3-27 02:17 作者: BACLE 時(shí)間: 2025-3-27 06:52
The Biochemistry of Blood Coagulationrculation disturbances in the legs, kidney disease etc. Thrombin generation therefore is a suitable subject of research in a biochemistry department of a medical faculty. On the other hand it shows so many novel features not recognized in enzymology until now, that it cannot fail to interest even th作者: TAIN 時(shí)間: 2025-3-27 13:24
Pathophysiology of Hemorrhagic Shock: Clinical and Therapeutic Implicationseen learned from these studies but the application to clinical conditions is often not as simple as is sometimes inferred. The differences in survival resulting from the use of different fluids in controlled studies do raise interesting questions however (Table I).作者: 襲擊 時(shí)間: 2025-3-27 16:05 作者: Endoscope 時(shí)間: 2025-3-27 21:51 作者: Soliloquy 時(shí)間: 2025-3-28 00:16
Blood Coagulation: Laboratory Practiceemostatic failure, to diagnose, investigate and if necessary treat a patient with bleeding tendency, and finally, to monitor the effects of blood component therapy. The tests used and the interpretations made depend on the clinical context. Therefore each of the three clinical situations will be dis作者: Phenothiazines 時(shí)間: 2025-3-28 04:40 作者: 并入 時(shí)間: 2025-3-28 10:13
Blood Components: Why and What for?n any of these functions may, at least in theory, be corrected by the transfusion of whole blood. Clinical experience has shown however that the relevant component in the blood donation is often present at a concentration too low to be effective. Increasing the volume of transfused blood, in an atte作者: palliate 時(shí)間: 2025-3-28 14:06 作者: HACK 時(shí)間: 2025-3-28 18:26 作者: 合唱隊(duì) 時(shí)間: 2025-3-28 21:37
Pathophysiology of Hemorrhagic Shock: Clinical and Therapeutic Implicationse with widespread and lasting deleterious effects is important. It implies that the therapeutic focus must be a broad one; the criteria for optimal treatment include much more than the restoration of the circulation to ‘normal’. Much of what we know about the effects of hemorrhage and its treatment 作者: Rodent 時(shí)間: 2025-3-29 01:16 作者: 溝通 時(shí)間: 2025-3-29 07:00
Disseminated Intravascular Coagulation and Its Impact on Blood Transfusionvariety of stimuli. It implies widespread deposition of altered fibrinogen and/or platelets, with concurrent obstruction of the microcirculation and desintegration of the hemostatic mechanism. The processes involved in DIC are triggered by an underlying pathological state and the sequences of DIC ag作者: 突襲 時(shí)間: 2025-3-29 07:23 作者: NEX 時(shí)間: 2025-3-29 13:35
ning has continued. It has greatly stimulated the in- terest in blood transfusion and all allied disciplines in our country. It is clear that these meetings are organized not only by a good scientist, but at the same time by a gifted or- ganizer who, as director of the Red Cross Blood Bank Gro- ning作者: Statins 時(shí)間: 2025-3-29 15:44
https://doi.org/10.1007/978-94-6091-591-8rved platelets from compatible donors for alloimmunized patients or patients before undergoing treatment, or when they are in remission (autologous platelets) for a longer period of time would be of considerable importance. With this in mind we conceived a platelet freezing program.作者: canvass 時(shí)間: 2025-3-29 23:16 作者: 實(shí)現(xiàn) 時(shí)間: 2025-3-30 01:46 作者: 上漲 時(shí)間: 2025-3-30 07:26 作者: BRIBE 時(shí)間: 2025-3-30 11:01 作者: 煩憂 時(shí)間: 2025-3-30 14:56
https://doi.org/10.1007/978-1-349-22466-1age directly attributable to thrombocytopenia (37), this figure has been radically lowered to no more than 10% to 20%, at this time. Chemotherapy and radiotherapy continue to push to the limits of bone marrow tolerance, and surgery is undertaken in thrombocytopenic patients formerly considered inoperable.作者: nostrum 時(shí)間: 2025-3-30 19:36
Platelet Therapyage directly attributable to thrombocytopenia (37), this figure has been radically lowered to no more than 10% to 20%, at this time. Chemotherapy and radiotherapy continue to push to the limits of bone marrow tolerance, and surgery is undertaken in thrombocytopenic patients formerly considered inoperable.